We're increasing our Eli Lilly price target after another beat-and-raise quarter
The strength of its GLP-1 business suggests the stock still has more room to run.
Overview
The strength of its GLP-1 business suggests the stock still has more room to run.
Source
Originally published at www.cnbc.com.
Related Articles
- How parents can keep saving for retirement during the expensive childcare years
- Changing how Medicare pays for hospice care could save the U.S. $7.6 billion a year — but at what cost to patients?
- Taxes are on the ballot this fall as Republicans and Democrats grow further apart on whether to raise them
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.